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Background & Introduction
• Pancreatic cancer cannot be cured without 
surgically removing the tumor from the 
pancreas. Only 10-15% of patients can have an 
operation because of late-stage diagnosis.
• The small intestine is one of the most 
radiosensitive tissues in the body. Due to the 
already sensitive nature of the tissue and the 
proximity to the pancreas there is great risk 
during pancreatic cancer radiation treatments. 
• The Taniguchi Lab previously found that 
stabilizing the expression of hypoxia-inducible 
factor 2 (HIF2) can improve survival in mouse 
models of radiation injury, however, the 
mechanisms of the effect are still unknown1. 
Methods
Preparation of human intestinal tissue(Fig. 2):
• Duodenal enteroids were generated from tissue 
obtained from patients during gastric bypass 
surgery through Baylor School of Medicine and 
MD Anderson. The intestinal stem cells were 
isolated and grown using the Clevers’ protocol4.
Discussion
• Treatment related gastrointestinal (GI) toxicity is 
likely the greatest barrier to improving treatment 
responses for unresectable pancreatic cancer. 
Efforts to improve patient outcomes prompts the 
Taniguchi lab focus on radioprotection. 
• Exploring the GI organoid phenotypes for study 
of HI2 pathway induced by EGLN inhibition is a 
step towards understanding the cellular changes 
taking place during radiotherapy.
• Continuing this approach should allow further 
characterization of human enteroids to 
understand the therapeutic capacity of EGLN 
inhibition to reduce radiation toxicity.
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Fig. 4  (A) Immunoblot shows that HIF2 is detectable after 24 hours and stabilized after 
48 hours. There are no detectable changes in protein levels of WNT5a. (B)The bar 
graph below shows fold change calculated with the data from two blots. 
Fig. 5 (A,B)Bar graphs show upregulation of WNT5a and PGK1 (the downstream 
targets of HIF2) mRNA levels after treatment with FG-4592(50uM). Adversely there is 
little expression when treated with HIF inhibitor PT-2399 (1.0uM).
Results
• Treatment with the hypoxia mimic, FG-4592, or 
HIF2 inhibitor, PT-2399, induced no 
morphological differences or toxicity in the 
enteroids (Fig. 3). Immunoblot analysis shows 
that HIF2 expression is maximally stabilized 
after 72 hours (Fig. 2).
• Since we did not find any changes in protein 
levels of target gene Wnt5a so we looked at the 
mRNA level. qRT–PCR analysis was performed 
for hypoxia target genes. This demonstrated an 
upregulation in WNT5A and PGK1 after 
treatment with FG-4592 (50uM) (Fig. 5).
Determining the role of HIF2 in the radiation 
response of human intestinal tissue:
• Enteroids were treated with hypoxia mimicking 
drug, FG-4592 (50uM), which inhibits the prolyl 
hydroxylation of HIF2. They were incubated, and 
at 24-, 48-, and 72- hours cell lysates for protein 
expression analysis were prepared for HIF2 
immunoblotting (1:500, NB100-122). We also 
dissected the downstream mechanism of HIF2 
pathway by using a HIF2 antagonist, PT-2399. We 
optimized the combination treatment of PT-2399 
(1.0uM) along with FG-4592 (50uM) for gene 
analysis by quantitative PCR.  
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Fig. 3  Images show enteroids before treatment (0 hours) and during FG-4592(50uM) 
+ PT-2399(1.0uM) treatment at 24-, 48-, and 72- hours. No morphological differences 
were observed. Density of cells in Matrigel increases with time from 0- to 72- hours. 
Fig. 1  The EGLN/HIF pathway. In normoxia HIF1/2ɑ is hydroxylated by the presence 
of oxygen and thus conjugated by VHL, tagging it for degradation. In hypoxia, there is 
no hydroxylation and the HIF1/2ɑ becomes stabilized. 
Fig. 2  The above diagram shows the preparation of cell suspension according to the 
Clevers’ protocol4. The below diagram shows cells plated and grown as organoids, to be 
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